Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol for behavioral disturbances in dementia
NL-OMON39470Phase 2Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium oxybate in Dementia (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Neuropsychiatric Inventory. Started Nov 2012; status: active, not recruiting.
02
Drugs
sodium oxybate
03
Conditions
Dementia
Beyond the preview
Go deeper on NL-OMON39470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39470.